Search for: "FOREST PHARMACEUTICALS, INC."
Results 161 - 177
of 177
Sort by Relevance
|
Sort by Date
4 Apr 2008, 1:00 am
: (IPBiz) Pharma & Biotech - Products Abilify (Aripiprazole) – Otsuka files US patent infringement suit against Teva over seeking approval for generic Abilify: (IP Law360), Aricept (Donepezil) – US federal judge grants Eisai’s request for preliminary injunction blocking Teva from marketing generic version of Aricept: (IP Law360), (Orange Book Blog), Carbatrol (Carbamazepine) – US federal judge delivers mixed ruling in Shire… [read post]
28 Mar 2008, 6:00 am
- Anonymity of policy research group quoted on pharma patenting policy and stats: (Spicy IP),Thailand: More news/reactions on compulsory licenses: (Generic Pharmaceuticals & IP),US: Follow-on biologic drugs and patent law: A potential disconnect? [read post]
23 Mar 2008, 8:45 pm
New Litigation filings: Plaintiffs: Forest Laboratories, Inc., Forest Laboratories Holdings, Ltd., Merz Pharmaceuticals GmbH and Merz Pharma GmbH & Co. [read post]
23 Mar 2008, 7:52 pm
Forest Laboratories, Inc. et al. v. [read post]
13 Feb 2008, 6:19 pm
#7: Forest Laboratories, Inc. v. [read post]
1 Feb 2008, 12:00 am
: (IPBiz),State of the Union address 28 Jan 2008: statement regarding patenting human life: (IPBiz), (Patently-O),Alnylam Pharmaceuticals secures UK patent covering molecules that affect RNA interference: (SmartBrief),Doha style compulsory licences for exports: The politics…: (Spicy IP),Pushing to compulsory licensing: Pharma companies heading closer to Doha: (Spicy IP),Financial Express on the battle between big pharma companies and the… [read post]
31 Jan 2008, 12:22 am
Pharmaceuticals for GlaxoSmithKline Christopher Viehbacher From Senate Finance Ranking Member Chuck Grassley (PDF 25.5 KB)Letter Requests Information About the Receipt of a Manuscript Before Publication in the New England Journal of Medicine01/30/2008
Letter to Secretary of Agriculture Ed Schafer From Sen. [read post]
17 Jan 2008, 10:00 pm
: (Against Monopoly),Structuring a decentralized world - Institute for Ethics and Emerging Technologies: The necessity of open biotechnology: (Patent Lens),A skeptical look at the Automated Content Access Protocol: (Ars Technica),5 practical things to incorporate in a corporate IP strategy: (IP ThinkTank), Legal models for online content enforcement: (OpenContentLawyer),Germany, Chinese copies and misdirected ‘strategy': (IP… [read post]
2 Oct 2007, 3:44 am
Ivax Pharmaceuticals, Inc., et al. (09/05/2007): appeal of order of district court entering judgment upholding the vailidity of reissue patent-in-suit and enjoining Ivax and Cipla from infringing the patent (affirmed, but injunction modified); discussion of patent related to an antidepressant composition (U.S. [read post]
12 Sep 2007, 4:59 am
Forest Labs., Inc. v. [read post]
Federal Circuit Invalidates Aventis's Altace Patent on Obviousness Grounds, Handing Victory to Lupin
11 Sep 2007, 9:55 pm
Teleflex Inc. . . . . [read post]
6 Sep 2007, 12:33 pm
Vutek, Inc., 174 F.3d 1352, 1356 (Fed. [read post]
5 Sep 2007, 8:38 pm
Noonan -- The Federal Circuit today affirmed a District Court finding that ANDA filer Ivax Pharmaceuticals and co-Defendant Cipla had not shown by clear and convincing evidence that Forest Laboratories' patent-in-suit for Lexapro ® was invalid. [read post]
5 Sep 2007, 3:50 pm
Forest Laboratories, Inc. v. [read post]
5 Sep 2007, 11:40 am
Ivax Pharmaceuticals, Inc., 07civ1059 (Fed. [read post]
5 Sep 2007, 11:40 am
Ivax Pharmaceuticals, Inc., 07civ1059 (Fed. [read post]
5 Apr 2007, 5:39 am
Bentex Pharmaceuticals, Inc., 412 U.S. 645, 653-54 (1973); Alpharma, Inc. v. [read post]
